APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Diseases Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liver Diseases Therapeutics Drugs Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchLiver Diseases Therapeutics Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Diseases Therapeutics Drugs Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Liver Diseases Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Diseases Therapeutics Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Diseases Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Liver Diseases Therapeutics Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liver Diseases Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liver Diseases Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liver Diseases Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liver Diseases Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liver Diseases Therapeutics Drugs include Achillion Pharmaceuticals, Angion Biomedica, F. Hoffmann-La Roche, Gilead Sciences, LG Life Sciences, Phenex Pharmaceuticals, ProMetic Life Sciences, Raptor Pharmaceuticals and Verva Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liver Diseases Therapeutics Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liver Diseases Therapeutics Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Liver Diseases Therapeutics Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Diseases Therapeutics Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liver Diseases Therapeutics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liver Diseases Therapeutics Drugs sales, projected growth trends, production technology, application and end-user industry.

Liver Diseases Therapeutics Drugs Segment by Company

Achillion Pharmaceuticals

Angion Biomedica

F. Hoffmann-La Roche

Gilead Sciences

LG Life Sciences

Phenex Pharmaceuticals

ProMetic Life Sciences

Raptor Pharmaceuticals

Verva Pharmaceuticals

AbbVie

Bayer

GlaxoSmithKline

Merck

Johnson & Johnson

Shenzhen Kangtai Biological Products

Liver Diseases Therapeutics Drugs Segment by Type

Oral Liver Diseases Therapeutics Drugs

Injection Liver Diseases Therapeutics Drugs

Liver Diseases Therapeutics Drugs Segment by Application

Hospitals

Clinics

Other

Liver Diseases Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Diseases Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Diseases Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Diseases Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liver Diseases Therapeutics Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liver Diseases Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Diseases Therapeutics Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Liver Diseases Therapeutics Drugs Major Manufacturers Table 3. Injection Liver Diseases Therapeutics Drugs Major Manufacturers Table 4. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Other Major Manufacturers Table 8. Liver Diseases Therapeutics Drugs Industry Trends Table 9. Liver Diseases Therapeutics Drugs Industry Drivers Table 10. Liver Diseases Therapeutics Drugs Industry Opportunities and Challenges Table 11. Liver Diseases Therapeutics Drugs Industry Restraints Table 12. Global Liver Diseases Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Liver Diseases Therapeutics Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Liver Diseases Therapeutics Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Liver Diseases Therapeutics Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Liver Diseases Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Liver Diseases Therapeutics Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 21. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2027-2032) Table 22. Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Liver Diseases Therapeutics Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Liver Diseases Therapeutics Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Liver Diseases Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Liver Diseases Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Liver Diseases Therapeutics Drugs Manufacturers, Product Type & Application Table 30. Global Liver Diseases Therapeutics Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Liver Diseases Therapeutics Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Liver Diseases Therapeutics Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Liver Diseases Therapeutics Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2021-2026) Table 42. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2027-2032) Table 43. Global Liver Diseases Therapeutics Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Liver Diseases Therapeutics Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Liver Diseases Therapeutics Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Liver Diseases Therapeutics Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2021-2026) Table 54. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2027-2032) Table 55. Global Liver Diseases Therapeutics Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Liver Diseases Therapeutics Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Achillion Pharmaceuticals Company Information Table 58. Achillion Pharmaceuticals Business Overview Table 59. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 61. Achillion Pharmaceuticals Recent Development Table 62. Angion Biomedica Company Information Table 63. Angion Biomedica Business Overview Table 64. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio Table 66. Angion Biomedica Recent Development Table 67. F. Hoffmann-La Roche Company Information Table 68. F. Hoffmann-La Roche Business Overview Table 69. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio Table 71. F. Hoffmann-La Roche Recent Development Table 72. Gilead Sciences Company Information Table 73. Gilead Sciences Business Overview Table 74. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 76. Gilead Sciences Recent Development Table 77. LG Life Sciences Company Information Table 78. LG Life Sciences Business Overview Table 79. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 81. LG Life Sciences Recent Development Table 82. Phenex Pharmaceuticals Company Information Table 83. Phenex Pharmaceuticals Business Overview Table 84. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 86. Phenex Pharmaceuticals Recent Development Table 87. ProMetic Life Sciences Company Information Table 88. ProMetic Life Sciences Business Overview Table 89. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio Table 91. ProMetic Life Sciences Recent Development Table 92. Raptor Pharmaceuticals Company Information Table 93. Raptor Pharmaceuticals Business Overview Table 94. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 96. Raptor Pharmaceuticals Recent Development Table 97. Verva Pharmaceuticals Company Information Table 98. Verva Pharmaceuticals Business Overview Table 99. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio Table 101. Verva Pharmaceuticals Recent Development Table 102. AbbVie Company Information Table 103. AbbVie Business Overview Table 104. AbbVie Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AbbVie Liver Diseases Therapeutics Drugs Product Portfolio Table 106. AbbVie Recent Development Table 107. Bayer Company Information Table 108. Bayer Business Overview Table 109. Bayer Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bayer Liver Diseases Therapeutics Drugs Product Portfolio Table 111. Bayer Recent Development Table 112. GlaxoSmithKline Company Information Table 113. GlaxoSmithKline Business Overview Table 114. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio Table 116. GlaxoSmithKline Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Liver Diseases Therapeutics Drugs Product Portfolio Table 121. Merck Recent Development Table 122. Johnson & Johnson Company Information Table 123. Johnson & Johnson Business Overview Table 124. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio Table 126. Johnson & Johnson Recent Development Table 127. Shenzhen Kangtai Biological Products Company Information Table 128. Shenzhen Kangtai Biological Products Business Overview Table 129. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio Table 131. Shenzhen Kangtai Biological Products Recent Development Table 132. North America Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 135. North America Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 136. North America Liver Diseases Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 137. North America Liver Diseases Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 138. North America Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 141. North America Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 142. North America Liver Diseases Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 143. North America Liver Diseases Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 144. North America Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. North America Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 149. North America Liver Diseases Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 150. North America Liver Diseases Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 151. North America Liver Diseases Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 152. United States Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 153. Canada Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 154. Europe Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 157. Europe Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 158. Europe Liver Diseases Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Europe Liver Diseases Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Europe Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 163. Europe Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 164. Europe Liver Diseases Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Europe Liver Diseases Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Europe Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 170. Europe Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 171. Europe Liver Diseases Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 172. Europe Liver Diseases Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Europe Liver Diseases Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Germany Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 175. France Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 176. U.K. Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 177. Italy Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 179. Nordic Countries Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 180. China Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 181. China Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 182. China Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 183. China Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 184. China Liver Diseases Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 185. China Liver Diseases Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 186. China Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 187. China Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 188. China Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 189. China Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 190. China Liver Diseases Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 191. China Liver Diseases Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 195. Asia Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 196. Asia Liver Diseases Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 197. Asia Liver Diseases Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 198. Asia Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 201. Asia Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 202. Asia Liver Diseases Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 203. Asia Liver Diseases Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Asia Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. Asia Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 209. Asia Liver Diseases Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 210. Asia Liver Diseases Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 211. Asia Liver Diseases Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Japan Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 213. South Korea Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 214. India Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 215. Australia Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 216. China Taiwan Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Liver Diseases Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA Liver Diseases Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA Liver Diseases Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 221. SAMEA Liver Diseases Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 222. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 223. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 224. SAMEA Liver Diseases Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Liver Diseases Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Liver Diseases Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 227. SAMEA Liver Diseases Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 228. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 229. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 230. SAMEA Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. SAMEA Liver Diseases Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 235. SAMEA Liver Diseases Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 236. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 237. SAMEA Liver Diseases Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Brazil Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 239. Argentina Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 240. Chile Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 241. Colombia Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 242. Peru Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 244. Israel Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 245. UAE Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 246. Turkey Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 247. Iran Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 248. Egypt Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Liver Diseases Therapeutics Drugs Distributors List Table 252. Liver Diseases Therapeutics Drugs Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Liver Diseases Therapeutics Drugs Image Figure 2. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Diseases Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Liver Diseases Therapeutics Drugs Image Figure 5. Injection Liver Diseases Therapeutics Drugs Image Figure 6. Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liver Diseases Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Other Image Figure 11. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Liver Diseases Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Liver Diseases Therapeutics Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Liver Diseases Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 17. Global Liver Diseases Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Liver Diseases Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Liver Diseases Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Liver Diseases Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Liver Diseases Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Liver Diseases Therapeutics Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Liver Diseases Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Liver Diseases Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Liver Diseases Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Liver Diseases Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Liver Diseases Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Liver Diseases Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Liver Diseases Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 40. North America Liver Diseases Therapeutics Drugs Sales Share by Type (2021-2032) Figure 41. North America Liver Diseases Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 42. North America Liver Diseases Therapeutics Drugs Sales Share by Application (2021-2032) Figure 43. North America Liver Diseases Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 44. North America Liver Diseases Therapeutics Drugs Sales Share by Country (2021-2032) Figure 45. Europe Liver Diseases Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Liver Diseases Therapeutics Drugs Sales Share by Type (2021-2032) Figure 47. Europe Liver Diseases Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Liver Diseases Therapeutics Drugs Sales Share by Application (2021-2032) Figure 49. Europe Liver Diseases Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Liver Diseases Therapeutics Drugs Sales Share by Country (2021-2032) Figure 51. China Liver Diseases Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 52. China Liver Diseases Therapeutics Drugs Sales Share by Type (2021-2032) Figure 53. China Liver Diseases Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 54. China Liver Diseases Therapeutics Drugs Sales Share by Application (2021-2032) Figure 55. Asia Liver Diseases Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Liver Diseases Therapeutics Drugs Sales Share by Type (2021-2032) Figure 57. Asia Liver Diseases Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Liver Diseases Therapeutics Drugs Sales Share by Application (2021-2032) Figure 59. Asia Liver Diseases Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Liver Diseases Therapeutics Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Liver Diseases Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Liver Diseases Therapeutics Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Liver Diseases Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Liver Diseases Therapeutics Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Liver Diseases Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Liver Diseases Therapeutics Drugs Sales Share by Country (2021-2032) Figure 67. Liver Diseases Therapeutics Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Liver Diseases Therapeutics Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Liver Diseases Therapeutics Drugs
  • Injection Liver Diseases Therapeutics Drugs
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Achillion Pharmaceuticals
  • Angion Biomedica
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • LG Life Sciences
  • Phenex Pharmaceuticals
  • ProMetic Life Sciences
  • Raptor Pharmaceuticals
  • Verva Pharmaceuticals
  • AbbVie
  • Bayer
  • GlaxoSmithKline
  • Merck
  • Johnson & Johnson
  • Shenzhen Kangtai Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liver Diseases Therapeutics Drugs Market by Type
  3. 1.2.1 Global Liver Diseases Therapeutics Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Liver Diseases Therapeutics Drugs
  5. 1.2.3 Injection Liver Diseases Therapeutics Drugs
  6. 1.3 Liver Diseases Therapeutics Drugs Market by Application
  7. 1.3.1 Global Liver Diseases Therapeutics Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Liver Diseases Therapeutics Drugs Market Dynamics
  1. 2.1 Liver Diseases Therapeutics Drugs Industry Trends
  2. 2.2 Liver Diseases Therapeutics Drugs Industry Drivers
  3. 2.3 Liver Diseases Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Liver Diseases Therapeutics Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liver Diseases Therapeutics Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liver Diseases Therapeutics Drugs Revenue by Region
  3. 3.2.1 Global Liver Diseases Therapeutics Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liver Diseases Therapeutics Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Liver Diseases Therapeutics Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liver Diseases Therapeutics Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liver Diseases Therapeutics Drugs Sales by Region
  9. 3.4.1 Global Liver Diseases Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liver Diseases Therapeutics Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Liver Diseases Therapeutics Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers
  2. 4.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liver Diseases Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liver Diseases Therapeutics Drugs Sales by Manufacturers
  6. 4.2.1 Global Liver Diseases Therapeutics Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liver Diseases Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liver Diseases Therapeutics Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liver Diseases Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liver Diseases Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liver Diseases Therapeutics Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Liver Diseases Therapeutics Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liver Diseases Therapeutics Drugs Market CR5 and HHI
  16. 4.8.2 2025 Liver Diseases Therapeutics Drugs Tier 1, Tier 2, and Tier 3
5 Liver Diseases Therapeutics Drugs Market by Type
  1. 5.1 Global Liver Diseases Therapeutics Drugs Revenue by Type
  2. 5.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liver Diseases Therapeutics Drugs Sales by Type
  6. 5.2.1 Global Liver Diseases Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liver Diseases Therapeutics Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liver Diseases Therapeutics Drugs Price by Type
6 Liver Diseases Therapeutics Drugs Market by Application
  1. 6.1 Global Liver Diseases Therapeutics Drugs Revenue by Application
  2. 6.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liver Diseases Therapeutics Drugs Sales by Application
  6. 6.2.1 Global Liver Diseases Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liver Diseases Therapeutics Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liver Diseases Therapeutics Drugs Price by Application
7 Company Profiles
  1. 7.1 Achillion Pharmaceuticals
  2. 7.1.1 Achillion Pharmaceuticals Company Information
  3. 7.1.2 Achillion Pharmaceuticals Business Overview
  4. 7.1.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  6. 7.1.5 Achillion Pharmaceuticals Recent Developments
  7. 7.2 Angion Biomedica
  8. 7.2.1 Angion Biomedica Company Information
  9. 7.2.2 Angion Biomedica Business Overview
  10. 7.2.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio
  12. 7.2.5 Angion Biomedica Recent Developments
  13. 7.3 F. Hoffmann-La Roche
  14. 7.3.1 F. Hoffmann-La Roche Company Information
  15. 7.3.2 F. Hoffmann-La Roche Business Overview
  16. 7.3.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio
  18. 7.3.5 F. Hoffmann-La Roche Recent Developments
  19. 7.4 Gilead Sciences
  20. 7.4.1 Gilead Sciences Company Information
  21. 7.4.2 Gilead Sciences Business Overview
  22. 7.4.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  24. 7.4.5 Gilead Sciences Recent Developments
  25. 7.5 LG Life Sciences
  26. 7.5.1 LG Life Sciences Company Information
  27. 7.5.2 LG Life Sciences Business Overview
  28. 7.5.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  30. 7.5.5 LG Life Sciences Recent Developments
  31. 7.6 Phenex Pharmaceuticals
  32. 7.6.1 Phenex Pharmaceuticals Company Information
  33. 7.6.2 Phenex Pharmaceuticals Business Overview
  34. 7.6.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  36. 7.6.5 Phenex Pharmaceuticals Recent Developments
  37. 7.7 ProMetic Life Sciences
  38. 7.7.1 ProMetic Life Sciences Company Information
  39. 7.7.2 ProMetic Life Sciences Business Overview
  40. 7.7.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
  42. 7.7.5 ProMetic Life Sciences Recent Developments
  43. 7.8 Raptor Pharmaceuticals
  44. 7.8.1 Raptor Pharmaceuticals Company Information
  45. 7.8.2 Raptor Pharmaceuticals Business Overview
  46. 7.8.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  48. 7.8.5 Raptor Pharmaceuticals Recent Developments
  49. 7.9 Verva Pharmaceuticals
  50. 7.9.1 Verva Pharmaceuticals Company Information
  51. 7.9.2 Verva Pharmaceuticals Business Overview
  52. 7.9.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
  54. 7.9.5 Verva Pharmaceuticals Recent Developments
  55. 7.10 AbbVie
  56. 7.10.1 AbbVie Company Information
  57. 7.10.2 AbbVie Business Overview
  58. 7.10.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AbbVie Liver Diseases Therapeutics Drugs Product Portfolio
  60. 7.10.5 AbbVie Recent Developments
  61. 7.11 Bayer
  62. 7.11.1 Bayer Company Information
  63. 7.11.2 Bayer Business Overview
  64. 7.11.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bayer Liver Diseases Therapeutics Drugs Product Portfolio
  66. 7.11.5 Bayer Recent Developments
  67. 7.12 GlaxoSmithKline
  68. 7.12.1 GlaxoSmithKline Company Information
  69. 7.12.2 GlaxoSmithKline Business Overview
  70. 7.12.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio
  72. 7.12.5 GlaxoSmithKline Recent Developments
  73. 7.13 Merck
  74. 7.13.1 Merck Company Information
  75. 7.13.2 Merck Business Overview
  76. 7.13.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Merck Liver Diseases Therapeutics Drugs Product Portfolio
  78. 7.13.5 Merck Recent Developments
  79. 7.14 Johnson & Johnson
  80. 7.14.1 Johnson & Johnson Company Information
  81. 7.14.2 Johnson & Johnson Business Overview
  82. 7.14.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio
  84. 7.14.5 Johnson & Johnson Recent Developments
  85. 7.15 Shenzhen Kangtai Biological Products
  86. 7.15.1 Shenzhen Kangtai Biological Products Company Information
  87. 7.15.2 Shenzhen Kangtai Biological Products Business Overview
  88. 7.15.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio
  90. 7.15.5 Shenzhen Kangtai Biological Products Recent Developments
8 North America
  1. 8.1 North America Liver Diseases Therapeutics Drugs Market Size by Type
  2. 8.1.1 North America Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Liver Diseases Therapeutics Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Liver Diseases Therapeutics Drugs Price by Type (2021-2032)
  5. 8.2 North America Liver Diseases Therapeutics Drugs Market Size by Application
  6. 8.2.1 North America Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Liver Diseases Therapeutics Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Liver Diseases Therapeutics Drugs Price by Application (2021-2032)
  9. 8.3 North America Liver Diseases Therapeutics Drugs Market Size by Country
  10. 8.3.1 North America Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liver Diseases Therapeutics Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Liver Diseases Therapeutics Drugs Market Size by Type
  2. 9.1.1 Europe Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liver Diseases Therapeutics Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Liver Diseases Therapeutics Drugs Price by Type (2021-2032)
  5. 9.2 Europe Liver Diseases Therapeutics Drugs Market Size by Application
  6. 9.2.1 Europe Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liver Diseases Therapeutics Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Liver Diseases Therapeutics Drugs Price by Application (2021-2032)
  9. 9.3 Europe Liver Diseases Therapeutics Drugs Market Size by Country
  10. 9.3.1 Europe Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liver Diseases Therapeutics Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Liver Diseases Therapeutics Drugs Market Size by Type
  2. 10.1.1 China Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Liver Diseases Therapeutics Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Liver Diseases Therapeutics Drugs Price by Type (2021-2032)
  5. 10.2 China Liver Diseases Therapeutics Drugs Market Size by Application
  6. 10.2.1 China Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Liver Diseases Therapeutics Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Liver Diseases Therapeutics Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liver Diseases Therapeutics Drugs Market Size by Type
  2. 11.1.1 Asia Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liver Diseases Therapeutics Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Liver Diseases Therapeutics Drugs Price by Type (2021-2032)
  5. 11.2 Asia Liver Diseases Therapeutics Drugs Market Size by Application
  6. 11.2.1 Asia Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liver Diseases Therapeutics Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Liver Diseases Therapeutics Drugs Price by Application (2021-2032)
  9. 11.3 Asia Liver Diseases Therapeutics Drugs Market Size by Country
  10. 11.3.1 Asia Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liver Diseases Therapeutics Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liver Diseases Therapeutics Drugs Market Size by Type
  2. 12.1.1 SAMEA Liver Diseases Therapeutics Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liver Diseases Therapeutics Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liver Diseases Therapeutics Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Liver Diseases Therapeutics Drugs Market Size by Application
  6. 12.2.1 SAMEA Liver Diseases Therapeutics Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liver Diseases Therapeutics Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liver Diseases Therapeutics Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Liver Diseases Therapeutics Drugs Market Size by Country
  10. 12.3.1 SAMEA Liver Diseases Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liver Diseases Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liver Diseases Therapeutics Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liver Diseases Therapeutics Drugs Value Chain Analysis
  2. 13.1.1 Liver Diseases Therapeutics Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liver Diseases Therapeutics Drugs Production Mode & Process
  6. 13.2 Liver Diseases Therapeutics Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liver Diseases Therapeutics Drugs Distributors
  9. 13.2.3 Liver Diseases Therapeutics Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst